Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy

Clinical trial NCT00035620 · COMPLETED

Trial details

NCT number: NCT00035620
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sarcoma Neutropenia

Start date: 2000-04-01
Primary completion: 2007-01-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.